Van Gool SW - Search Results

1

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.

Rutkowski S, De Vleeschouwer S, Kaempgen E, Wolff JE, Kühl J, Demaerel P, Warmuth-Metz M, Flamen P, Van Calenbergh F, Plets C, Sörensen N, Opitz A, Van Gool SW. Rutkowski S, et al. Among authors: van gool sw, van calenbergh f. Br J Cancer. 2004 Nov 1;91(9):1656-62. doi: 10.1038/sj.bjc.6602195. Br J Cancer. 2004. PMID: 15477864 Free PMC article.

2

Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies.

Kramm CM, Wagner S, Van Gool S, Schmid H, Sträter R, Gnekow A, Rutkowski S, Wolff JE. Kramm CM, et al. Anticancer Res. 2006 Sep-Oct;26(5B):3773-9. Anticancer Res. 2006. PMID: 17094400 Free article.

3

Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro.

Knüpfer MM, Poppenborg H, Van Gool S, Domula M, Wolff JE. Knüpfer MM, et al. Klin Padiatr. 1997 Jul-Aug;209(4):271-4. doi: 10.1055/s-2008-1043961. Klin Padiatr. 1997. PMID: 9293461

4

Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro.

Knüpfer MM, Knüpfer H, Van Gool S, Domula M, Wolff JE. Knüpfer MM, et al. Cytokine. 2000 Apr;12(4):409-12. doi: 10.1006/cyto.1999.0575. Cytokine. 2000. PMID: 10805225

5

Interferon-gamma inhibits growth and migration of A172 human glioblastoma cells.

Knüpfer MM, Knüpfer H, Jendrossek V, Van Gool S, Wolff JE, Keller E. Knüpfer MM, et al. Anticancer Res. 2001 Nov-Dec;21(6A):3989-94. Anticancer Res. 2001. PMID: 11911281

6

Interferon-gamma increases IL-6 production in human glioblastoma cell lines.

Hotfilder M, Knupfer H, Mohlenkamp G, Pennekamp P, Knupfers M, Van Gool S, Wolff JE. Hotfilder M, et al. Anticancer Res. 2000 Nov-Dec;20(6B):4445-50. Anticancer Res. 2000. PMID: 11205286

7

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients.

Van Gool SW, Van de Vliet P, Kampers LFC, Kosmal J, Sprenger T, Reich E, Schirrmacher V, Stuecker W. Van Gool SW, et al. Methods Cell Biol. 2024;183:51-113. doi: 10.1016/bs.mcb.2023.06.001. Epub 2023 Oct 19. Methods Cell Biol. 2024. PMID: 38548421

8

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

Van Gool SW, Makalowski J, Kampers LFC, Van de Vliet P, Sprenger T, Schirrmacher V, Stücker W. Van Gool SW, et al. Transl Cancer Res. 2023 Aug 31;12(8):2224-2228. doi: 10.21037/tcr-23-603. Epub 2023 Jul 28. Transl Cancer Res. 2023. PMID: 37701100 Free PMC article. No abstract available.

9

The Application of Evidence-Based Medicine in Individualized Medicine.

Van de Vliet P, Sprenger T, Kampers LFC, Makalowski J, Schirrmacher V, Stücker W, Van Gool SW. Van de Vliet P, et al. Among authors: van gool sw. Biomedicines. 2023 Jun 23;11(7):1793. doi: 10.3390/biomedicines11071793. Biomedicines. 2023. PMID: 37509433 Free PMC article.

10

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience.

Van Gool SW, Makalowski J, Van de Vliet P, Van Gool S, Sprenger T, Schirrmacher V, Stuecker W. Van Gool SW, et al. Cancers (Basel). 2023 Feb 13;15(4):1194. doi: 10.3390/cancers15041194. Cancers (Basel). 2023. PMID: 36831536 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page